Federation des caisses Desjardins du Quebec’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-825	Closed	-$206	–	2743
2024 Q2	$206	Hold	825	–	–	﹤0.01%	2327
2024 Q1	$592	Hold	825	–	–	﹤0.01%	2228
2023 Q4	$701	Hold	825	–	–	﹤0.01%	2176
2023 Q3	$1.13K	Hold	825	–	–	﹤0.01%	2143
2023 Q2	$2.08K	Hold	825	–	–	﹤0.01%	2052
2023 Q1	$1.87K	Hold	825	–	–	﹤0.01%	2087
2022 Q4	$1.16K	Buy	+825	New	+$1.39K	﹤0.01%	2266

Federation des caisses Desjardins du Quebec's VAXX Position: Q3 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2024, closing a stake of 825 shares — an estimated $206 sold.

Federation des caisses Desjardins du Quebec first reported a position in VAXX in Q4 2022 and held it in 7 quarters. The position peaked at $2.08K in Q2 2023. 0 funds tracked by Wall St. Rank hold VAXX as of Q3 2024.

Federation des caisses Desjardins du Quebec reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 825 Vaxxinity, Inc. Class A Common Stock shares in Q3 2024, an estimated $206.
Federation des caisses Desjardins du Quebec first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2022 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Vaxxinity, Inc. Class A Common Stock position peaked at $2.08K in Q2 2023.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2024, filed 13 Nov 2024.